Patients

Helping you reach a healthy life, full of possibility.

Patients

Healthcare Professionals

Committed to helping you meet the evolving challenges and opportunities in patient care.

Healthcare Professionals

Perspectives

For more than 85-years, we have worked at the intersection of saving and sustaining lives.

Perspectives

Our Story

Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story

Investors

Our objective is to accelerate growth by expanding Baxter’s impact across the healthcare spectrum supported by the evolution of our new product pipeline.

Investors
Home  >  Investors  >  Events & News  >  News  >  Press Release Details

Press Release Details

Press Release Details

All News

Baxter Declares Quarterly Dividend and Announces Expanded Share Repurchase Authorization

Nov 13, 2018

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today a quarterly cash dividend and an expanded authorization for its share repurchase program.

The Board of Directors of Baxter has declared a quarterly cash dividend of $0.19 per share of common stock, payable on Jan. 2, 2019, to stockholders of record as of Dec. 3, 2018. The indicated annual dividend rate is $0.76 per share of common stock.

Baxter’s Board of Directors has also approved a $2.0 billion increase in authorization for the company’s existing share repurchase plan. Based on these actions, the share repurchase plan has approximately $3.4 billion of repurchase authority available as of the date hereof to make repurchases pursuant to new or existing Rule 10b5-1 plans or otherwise. Shares will be repurchased in the open market or through private transactions at times and amounts determined by the company based on its evaluation of market conditions and other factors and, if applicable, in accordance with the terms of one or more Rule 10b5-1 plans.

“Baxter’s strong balance sheet allows us to serve our shareholders by investing in growth as well as returning value through dividends and share repurchases,” said Jay Saccaro, Baxter’s chief financial officer.

About Baxter

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.

This release includes forward-looking statements concerning Baxter's dividend and potential share repurchase activity. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: continued strength in the company’s financial position, including cash flows; alternative uses of funds including, but not limited to dividends, share repurchases, business development transactions and other investments in the company’s businesses; and other risks identified in the company's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter’s website. Baxter does not undertake to update its forward-looking statements.

Baxter is a registered trademark of Baxter International Inc.

Baxter International Inc.
Media Contact
Steve Brett, (224) 948-5353
media@baxter.com
or
Investor Contact
Clare Trachtman, (224) 948-3085

Source: Baxter International Inc.

Categories: Press Releases
All News